Alembic Pharmaceuticals informs about press release

26 Oct 2020 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% and 0.5%. In this regard the company has enclosed its press release on 26th October 2020.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

844.75 8.95 (1.07%)
31-Dec-2025 14:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1270.00
Cipla 1508.00
Zydus Lifesciences 913.00
Lupin 2110.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×